Oxford Biodynamics (OBD) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Apr 2025 04:10 PM
RNS
Director/PDMR Shareholding
02 Apr 2025 07:00 AM
RNS
PDMR Dealing
28 Mar 2025 10:35 AM
RNS
Result of AGM
17 Mar 2025 07:00 AM
RNS
Board Changes
14 Mar 2025 05:25 PM
RNS
Holding(s) in Company
13 Mar 2025 07:00 AM
RNS
Expansion of OBD/Bupa UK insurance partnership
05 Mar 2025 04:00 PM
RNS
Publication of 2024 Annual Report
03 Mar 2025 07:00 AM
RNS
PDMR Dealing / Grant of Share Options
28 Feb 2025 07:00 AM
RNS
Preliminary Results and Notice of AGM
21 Feb 2025 10:00 AM
RNS
Notice of Preliminary Results
17 Feb 2025 01:07 PM
RNS
Holding(s) in Company
12 Feb 2025 04:48 PM
RNS
Holding(s) in Company
12 Feb 2025 07:00 AM
RNS
OBD partners with Regina Maria in Romania
10 Feb 2025 12:09 PM
RNS
Holding(s) in Company
06 Feb 2025 01:43 PM
RNS
Holding(s) in Company
06 Feb 2025 10:46 AM
RNS
Holding(s) in Company
06 Feb 2025 07:00 AM
RNS
Holding(s) in Company
05 Feb 2025 02:13 PM
RNS
Holding(s) in Company
05 Feb 2025 02:11 PM
RNS
Holding(s) in Company
05 Feb 2025 07:00 AM
RNS
CRC Test Accurately Detects Cancer and Polyps
04 Feb 2025 02:38 PM
RNS
Holding(s) in Company
31 Jan 2025 12:00 PM
RNS
Result of GM and Director Dealings
23 Jan 2025 07:00 AM
RNS
CiRT: Real World Data Presented at ASCO-GI
17 Jan 2025 07:00 AM
RNS
Result of WRAP Retail Offer
15 Jan 2025 07:00 AM
RNS
Result of Placing and Subscription
14 Jan 2025 05:09 PM
RNS
WRAP Retail Offer
14 Jan 2025 04:35 PM
RNS
Proposed Fundraising
24 Dec 2024 07:00 AM
RNS
Issue of shares, Director / PDMR holdings and TVR
19 Dec 2024 02:41 PM
RNS
Shareholder Loan and Related Party Transaction
16 Dec 2024 07:00 AM
RNS
Directorate Change, Funding Update & Joint Broker
06 Dec 2024 04:05 PM
RNS
Holding(s) in Company
03 Dec 2024 04:41 PM
RNS
Response to Share Price Movement
29 Nov 2024 11:40 AM
RNS
Director/PDMR Shareholding
28 Oct 2024 12:12 PM
RNS
Director / PDMR holdings and Total Voting Rights
25 Oct 2024 07:00 AM
RNS
Prognostic Covid Severity Test Study Published
22 Oct 2024 01:00 PM
RNS
CiRT Receives Clinical Approval from NYS CLEP
15 Oct 2024 02:34 PM
RNS
Holding(s) in Company
14 Oct 2024 07:00 AM
RNS
Commercial update for FY24
07 Oct 2024 07:01 AM
RNS
Holding(s) in Company
07 Oct 2024 07:00 AM
RNS
CIRRP Award Update
11 Sep 2024 12:55 PM
RNS
Holding(s) in Company
22 Aug 2024 04:59 PM
RNS
Holding(s) in Company
22 Aug 2024 11:41 AM
RNS
Holding(s) in Company
25 Jul 2024 07:00 AM
RNS
OBD pursuing EpiSwitch as companion diagnostics
21 Jun 2024 03:42 PM
RNS
Grant of Options
18 Jun 2024 07:00 AM
RNS
Half-year Report
06 Jun 2024 07:00 AM
RNS
OBD's PSE test to be used in NCI trial
04 Jun 2024 07:00 AM
RNS
OBD develops multi-cancer diagnostic test for dogs
24 May 2024 07:00 AM
RNS
Notice of Results
23 May 2024 07:00 AM
RNS
OBD partners with Goodbody Clinic on PSE test

Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.

OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.

OBD share price launched at 162p in 2016.

UK 100

Latest directors dealings